5:18 PM
 | 
Jul 18, 2013
 |  BC Extra  |  Financial News

NGM raises $50 million in series C

NGM Biopharmaceuticals Inc. (South San Francisco, Calif.) raised $50 million in a series C round from new investor Topspin Fund...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >